GC Biopharma Balance Sheet Health
Financial Health criteria checks 2/6
GC Biopharma has a total shareholder equity of ₩1,494.2B and total debt of ₩693.8B, which brings its debt-to-equity ratio to 46.4%. Its total assets and total liabilities are ₩2,685.0B and ₩1,190.8B respectively. GC Biopharma's EBIT is ₩32.5B making its interest coverage ratio 1.1. It has cash and short-term investments of ₩64.8B.
Key information
46.4%
Debt to equity ratio
₩693.80b
Debt
Interest coverage ratio | 1.1x |
Cash | ₩64.79b |
Equity | ₩1.49t |
Total liabilities | ₩1.19t |
Total assets | ₩2.68t |
Recent financial health updates
Is GC Biopharma (KRX:006280) A Risky Investment?
May 25We Think Green Cross (KRX:006280) Can Stay On Top Of Its Debt
May 02Green Cross (KRX:006280) Has A Somewhat Strained Balance Sheet
Jan 31Recent updates
There's No Escaping GC Biopharma Corp.'s (KRX:006280) Muted Revenues
Aug 02A Look At The Fair Value Of GC Biopharma Corp. (KRX:006280)
Jul 12Is GC Biopharma (KRX:006280) A Risky Investment?
May 25GC Biopharma Corp.'s (KRX:006280) Business And Shares Still Trailing The Industry
Mar 08We Think Green Cross (KRX:006280) Can Stay On Top Of Its Debt
May 02Are Green Cross Corporation's (KRX:006280) Mixed Financials Driving The Negative Sentiment?
Mar 10Shareholders Are Thrilled That The Green Cross (KRX:006280) Share Price Increased 268%
Feb 18Green Cross (KRX:006280) Has A Somewhat Strained Balance Sheet
Jan 31Calculating The Intrinsic Value Of Green Cross Corporation (KRX:006280)
Jan 14What You Need To Know About Green Cross Corporation's (KRX:006280) Investor Composition
Dec 27Green Cross Corporation's (KRX:006280) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Dec 09Does Green Cross's (KRX:006280) Statutory Profit Adequately Reflect Its Underlying Profit?
Nov 21Financial Position Analysis
Short Term Liabilities: A006280's short term assets (₩1,107.0B) exceed its short term liabilities (₩803.8B).
Long Term Liabilities: A006280's short term assets (₩1,107.0B) exceed its long term liabilities (₩387.0B).
Debt to Equity History and Analysis
Debt Level: A006280's net debt to equity ratio (42.1%) is considered high.
Reducing Debt: A006280's debt to equity ratio has increased from 32.7% to 46.4% over the past 5 years.
Debt Coverage: A006280's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: A006280's interest payments on its debt are not well covered by EBIT (1.1x coverage).